Organization
Immunogen Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Immunogen Inc.
... IDRA), Inovio Pharmaceuticals Inc. (NASDAQ: INO), OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), ImmunoGen, Inc. (NASDAQ: IMGN). "Rising incidence of oncology diseases is anticipated to drive the ...
... If you want a Stock Review on IMGN, INCY, INFI, or INSM then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... third quarter of 2017 included an upfront payment of $75.0 million to ImmunoGen, Inc. related to a collaboration and option agreement. Adjusted net income for ...
... ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... to keep track of include:Propanc Biopharma, Inc.(OTC: PPCB),Inovio Pharmaceuticals, Inc.(NASDAQ: INO), ImmunoGen, Inc.(NASDAQ: IMGN),Verastem, Inc.(NASDAQ: VSTM). Propanc Biopharma, Inc.(OTCQB: PPCB) Market Cap: $1.2M, current share ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc. (NASDAQ: IMGN) today announced the closing of its previously announced underwritten public ...
... patient's own immune system the other targets the metabolism of tumors. ImmunoGen, Inc.(NASDAQ: IMGN) Market Cap: $858.49M, current share price: $7.65 IMGNis a clinical-stage biotechnology ...
... If you want a Stock Review on IMGN, INCY, INFI, or INSM then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... ImmunoGen, Inc. (NASDAQ: IMGN) today announced that it intends to offer and sell, subject ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc. (NASDAQ:IMGN) ("ImmunoGen" or the "Company") today announced that it has entered into ...
... Four years ago, ImmunoGen Inc. marked a significant achievement in the Waltham company's history with the ...
... million and committing to $100 million in R&D funding to buy into ImmunoGen’s early-stage pipeline. The deal gives Jazz an option to pick up worldwide ...
... Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and ImmunoGen, Inc. (Nasdaq: IMGN) today announced that the companies have entered into a collaboration ...
... If you want a Stock Review on IMGN, INCY, INFI, or JAZZ then come over to http://dailystocktracker.com/register/and sign up for ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc . (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... to cancer cells. In 2014, CytomX entered into a license agreement with ImmunoGen, Inc. to develop PDCs against a defined number of targets, bringing together ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤